Cat. No.: DIA-0230049
Product Information | |
---|---|
CAS No. | 857064-38-1 |
Formula | C17H14BrN3O |
Molecular Weight | 356.22 |
SMILES | CC(NC(=O)\C(=C\C1=NC(=CC=C1)Br)C#N)C2=CC=CC=C2 |
Target | JAK2 and STAT3 |
Product Description | WP1066 is a novel inhibitor of JAK2 and STAT3 with IC50 of 2.30 μM and 2.43 μM in HEL cells shows activity to JAK2, STAT3, STAT5, and ERK1/2 not JAK1 and JAK3. Phase 1. |
Format & Storage | |
---|---|
Purity | > 99% |
Shipping | Shipped on dry ice. |
Storage | Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.